100
Views
11
CrossRef citations to date
0
Altmetric
Case Reports

Fulminant Idiopathic Intracranial Hypertension With Malignant Systemic Hypertension—A Case Report

, &
Pages 120-123 | Received 19 Nov 2012, Accepted 10 Mar 2013, Published online: 31 May 2013

References

  • Sinclair AJ, Ball AK, Burdon MA, Clarke CE, Stewart PM, Curnow SJ, Rauz S. Exploring the pathogenesis of IIH: an inflammatory perspective. J Neuroimmunol 2008;201:212–220
  • Thambisetty M, Lavin PJ, Newmand NJ, Biousse V. Fulminant Idiopathic intracranial hypertension. Neurology 2007;68:229–232
  • Acheson JF. Idiopathic intracranial hypertension and visual function. Br Med Bull 2006;79–80:233–234
  • Mensah A, Milea D, Jensen R, Fledelius H. Persistent visual Loss in malignant idiopathic intracranial hypertension. Acta Ophthamol 2009;87:935–937
  • Trobe JD. Papilledema: the vexing issues. J Neuroophthal 2011;31:175–186
  • Hayreh SS. Optic disc edema in raised intracranial pressure V. Pathogenesis. Arch Ophthalmol 1977;95:1553–1565
  • Corbett JJ, Savino PJ, Thompson KS, Schatz NJ, Orr LS, Hopson D. Visual loss in pseudotumour cerebri: follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent, severe visual loss. Arch Neurol 1982;39:461–474
  • Hayreh SS, Servais GE, Virdi PS. Fundus lesions in malignant hypertension V. Hypertensive optic neuropathy. Ophthalmology 1986;93:74–87
  • Shah VA, Kardon RH, Lee AG, Corbett JJ, Wall M. Long-term follow up of idiopathic intracranial hypertension: the Iowa experience. Neurology 2008;70:634–640
  • Galvin JA, von Stavern GP. Clinical characteristics of idiopathic intracranial hypertension at the Detroit Medical Center. J Neurol Sci 2004;223:157–160
  • Saguner A M, Dür S, Perrig M, Schiemann U, Stuck AE, Bürgi U, Erne P, Schoenenberger AW. Risk factors promoting hypertensive crises: evidence from a longitudinal study. Am J Hypertens 2010;23:775–780
  • Tielten CS, Hum PD, Ulatowski JA, Kirsch JR. Treatment modalities for hypertensive patients with intracranial pathology. Options and risks. Crit Care Med 1996;24:311–322
  • Chitalia N, Weeg N, Antonios TF. Aldosterone-producing adrenal adenoma and idiopathic intracranial hypertension—a pathogenetic link for aldosterone? Q J Med 2010;103:699–702
  • Weber KT, Singh KD, Hey CJ. Idiopathic intracranial hypertension with primary hyperaldosteronism: report of two cases. Am J Med Sci 2002;324:45–50
  • Wan WH, Ang BT, Wang E. The Cushing response: a case for a review of its role as a physiological reflex. J Clin Neurosci 2008;15:223–228
  • Lip PL, Burdon MA, Clarke CE, Beevers DG, Kip LYH. Lone papilloedema. Lancet 2001;357:1924

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.